Khan Inamullah, Shakir Muhammad, Hika Busha, Khan Musharaf, Bhatti Ibrahim Ahmad, Qureshi Adnan I, Thomas Ajith, Kan Peter, Siddiq Farhan
Department of Neurosurgery, University of Missouri, Columbia, Missouri, USA.
Department of Neurosurgery, University of Missouri, Columbia, Missouri, USA.
World Neurosurg. 2024 Nov;191:291-302.e1. doi: 10.1016/j.wneu.2024.09.002. Epub 2024 Sep 6.
Conservative treatments for minimally symptomatic chronic subdural hematoma (cSDH) are debated, with surgery as the primary option.
To assess failure rates of a conservative approach for management of cSDH.
We searched PubMed, SCOPUS, Web of Science, and ClinicalTrials.gov for studies on conservative management of cSDH and analyzed the data using R (version 4.1.2).
A total of 35 studies including 2095 patients were analyzed: 950 (45%) of the patients were in the observation group, 671 (32%) in the corticosteroid group, 355 (17%) in the atorvastatin group, 43 (2%) in the mannitol group, 52 (2.5%) in the tranexamic acid group, and 24 (1.1%) in the etizolam group. Our pooled analysis showed that 19.82% of patients required rescue surgery (95% confidence interval [CI]: 12.98% to 26.66%, P < 0.0001). The overall pooled risk ratio (RR) for the effect of interventions on the need for rescue surgery was 0.2424 (95% CI: 0.1577 to 0.3725, Iˆ2 = 90.5%, P < 0.0001). Subgroup analysis showed varied effects: observation group (RR = 0.3482, 95% CI: 0.1045 to 1.1609, Iˆ2 = 94.0%), corticosteroids (RR = 0.2988, 95% CI: 0.1671 to 0.5344, Iˆ2 = 90.8%), atorvastatin (RR = 0.1609, 95% CI: 0.0985 to 0.2627, Iˆ2 = 53.2%), mannitol (RR = 0.0370, 95% CI: 0.0009 to 1.5244), and tranexamic acid (RR = 0.0585, 95% CI: 0.0026 to 1.2924).
The rate of rescue surgery in conservatively managed cSDH patients remains high. Corticosteroids or atorvastatin demonstrates some potential benefit in reducing the failure rate but collective effectiveness is unknown.
对于症状轻微的慢性硬膜下血肿(cSDH)的保守治疗存在争议,手术是主要选择。
评估cSDH保守治疗方法的失败率。
我们在PubMed、SCOPUS、科学网和ClinicalTrials.gov上搜索有关cSDH保守治疗的研究,并使用R(版本4.1.2)分析数据。
共分析了35项研究,包括2095例患者:950例(45%)患者在观察组,671例(32%)在皮质类固醇组,355例(17%)在阿托伐他汀组,43例(2%)在甘露醇组,52例(2.5%)在氨甲环酸组,24例(1.1%)在艾司唑仑组。我们的汇总分析表明,19.82%的患者需要挽救性手术(95%置信区间[CI]:12.98%至26.66%,P<0.0001)。干预措施对挽救性手术需求影响的总体汇总风险比(RR)为0.2424(95%CI:0.1577至0.3725,Iˆ2 = 90.5%,P<0.0001)。亚组分析显示效果各异:观察组(RR = 0.3482,95%CI:0.1045至1.1609,Iˆ2 = 94.0%),皮质类固醇(RR = 0.2988,95%CI:0.1671至0.5344,Iˆ2 = 90.8%),阿托伐他汀(RR = 0.1609,95%CI:0.0985至0.2627,Iˆ2 = 53.2%),甘露醇(RR = 0.0370,95%CI:0.0009至1.5244),以及氨甲环酸(RR = 0.0585,95%CI:0.0026至1.2924)。
接受保守治疗的cSDH患者的挽救性手术率仍然很高。皮质类固醇或阿托伐他汀在降低失败率方面显示出一些潜在益处,但总体有效性尚不清楚。